These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Janus Kinase 3, a Novel Regulator for Smooth Muscle Proliferation and Vascular Remodeling. Wang YC; Cui XB; Chuang YH; Chen SY Arterioscler Thromb Vasc Biol; 2017 Jul; 37(7):1352-1360. PubMed ID: 28473442 [TBL] [Abstract][Full Text] [Related]
7. RACing up a new regulatory mechanism for vascular smooth muscle cell migration. Lyle AN; Taylor WR Arterioscler Thromb Vasc Biol; 2013 Apr; 33(4):667-9. PubMed ID: 23486767 [No Abstract] [Full Text] [Related]
8. Cortistatin inhibits migration and proliferation of human vascular smooth muscle cells and decreases neointimal formation on carotid artery ligation. Duran-Prado M; Morell M; Delgado-Maroto V; Castaño JP; Aneiros-Fernandez J; de Lecea L; Culler MD; Hernandez-Cortes P; O'Valle F; Delgado M Circ Res; 2013 May; 112(11):1444-55. PubMed ID: 23595952 [TBL] [Abstract][Full Text] [Related]
9. The induction of yes-associated protein expression after arterial injury is crucial for smooth muscle phenotypic modulation and neointima formation. Wang X; Hu G; Gao X; Wang Y; Zhang W; Harmon EY; Zhi X; Xu Z; Lennartz MR; Barroso M; Trebak M; Chen C; Zhou J Arterioscler Thromb Vasc Biol; 2012 Nov; 32(11):2662-9. PubMed ID: 22922963 [TBL] [Abstract][Full Text] [Related]
10. Macrophage-derived MMP-8 determines smooth muscle cell differentiation from adventitia stem/progenitor cells and promotes neointima hyperplasia. Yang F; Chen Q; Yang M; Maguire EM; Yu X; He S; Xiao R; Wang CS; An W; Wu W; Zhou Y; Xiao Q; Zhang L Cardiovasc Res; 2020 Jan; 116(1):211-225. PubMed ID: 30778537 [TBL] [Abstract][Full Text] [Related]
11. Dedicator of cytokinesis 2, a novel regulator for smooth muscle phenotypic modulation and vascular remodeling. Guo X; Shi N; Cui XB; Wang JN; Fukui Y; Chen SY Circ Res; 2015 May; 116(10):e71-80. PubMed ID: 25788409 [TBL] [Abstract][Full Text] [Related]
12. Pharmacological Targeting of Plasminogen Activator Inhibitor-1 Decreases Vascular Smooth Muscle Cell Migration and Neointima Formation. Ji Y; Weng Z; Fish P; Goyal N; Luo M; Myears SP; Strawn TL; Chandrasekar B; Wu J; Fay WP Arterioscler Thromb Vasc Biol; 2016 Nov; 36(11):2167-2175. PubMed ID: 27659097 [TBL] [Abstract][Full Text] [Related]
13. Deletion of Krüppel-like factor 4 in endothelial and hematopoietic cells enhances neointimal formation following vascular injury. Yoshida T; Yamashita M; Horimai C; Hayashi M J Am Heart Assoc; 2014 Jan; 3(1):e000622. PubMed ID: 24470523 [TBL] [Abstract][Full Text] [Related]
15. Epac1 Deficiency Attenuated Vascular Smooth Muscle Cell Migration and Neointimal Formation. Kato Y; Yokoyama U; Yanai C; Ishige R; Kurotaki D; Umemura M; Fujita T; Kubota T; Okumura S; Sata M; Tamura T; Ishikawa Y Arterioscler Thromb Vasc Biol; 2015 Dec; 35(12):2617-25. PubMed ID: 26427796 [TBL] [Abstract][Full Text] [Related]
16. Deletion of Methionine Sulfoxide Reductase A Does Not Affect Atherothrombosis but Promotes Neointimal Hyperplasia and Extracellular Signal-Regulated Kinase 1/2 Signaling. Klutho PJ; Pennington SM; Scott JA; Wilson KM; Gu SX; Doddapattar P; Xie L; Venema AN; Zhu LJ; Chauhan AK; Lentz SR; Grumbach IM Arterioscler Thromb Vasc Biol; 2015 Dec; 35(12):2594-604. PubMed ID: 26449752 [TBL] [Abstract][Full Text] [Related]
17. Role of cAMP-phosphodiesterase 1C signaling in regulating growth factor receptor stability, vascular smooth muscle cell growth, migration, and neointimal hyperplasia. Cai Y; Nagel DJ; Zhou Q; Cygnar KD; Zhao H; Li F; Pi X; Knight PA; Yan C Circ Res; 2015 Mar; 116(7):1120-32. PubMed ID: 25608528 [TBL] [Abstract][Full Text] [Related]
18. A role for Gab1/SHP2 in thrombin activation of PAK1: gene transfer of kinase-dead PAK1 inhibits injury-induced restenosis. Wang D; Paria BC; Zhang Q; Karpurapu M; Li Q; Gerthoffer WT; Nakaoka Y; Rao GN Circ Res; 2009 May; 104(9):1066-75. PubMed ID: 19359598 [TBL] [Abstract][Full Text] [Related]